Edgewise Therapeutics (EWTX) PT Raised to $66 at Raymond James

June 1, 2026 2:16 PM

Raymond James analyst Martin Auster raised the price target on Edgewise Therapeutics (NASDAQ: EWTX) to $66.00 (from $52.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found